GOODWILL E-HEALTH INFO CO., LTD. Goodwill E-Health Info Co., Ltd. Stock
Equities
688246
CNE1000055V0
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.98 CNY | -1.18% |
|
+12.18% | -22.26% |
| Sales 2024 * | 878M 121M | Sales 2025 * | 1.39B 192M | Capitalization | 3.6B 497M |
|---|---|---|---|---|---|
| Net income 2024 * | 112M 15.47M | Net income 2025 * | 178M 24.58M | EV / Sales 2024 * | 4.1 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.59 x |
| P/E ratio 2024 * |
32.1
x | P/E ratio 2025 * |
20.2
x | Employees | 2,050 |
| Yield 2024 * |
1.15% | Yield 2025 * |
1.46% | Free-Float | 49.47% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.18% | ||
| 1 week | +12.18% | ||
| Current month | +9.30% | ||
| 1 month | +19.61% | ||
| 3 months | +8.98% | ||
| 6 months | -25.92% | ||
| Current year | -22.26% |
1 week
22.69
27.70
1 month
22.2227.70
Current year
17.1034.21
1 year
17.1045.48
3 years
17.1053.88
5 years
17.1053.88
10 years
17.1053.88
| Managers | Title | Age | Since |
|---|---|---|---|
Yong Ren
FOU | Founder | 54 | 06-03-02 |
Jun Xia
CEO | Chief Executive Officer | 56 | 06-03-02 |
Lian Zhong Chen
CTO | Chief Tech/Sci/R&D Officer | 49 | 19-05-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jun Xia
CEO | Chief Executive Officer | 56 | 06-03-02 |
Xiang Xin Shi
BRD | Director/Board Member | 68 | 19-06-30 |
Ting Cai
CHM | Chairman | 51 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-24 | 25.98 | -1.18% | 3,208,578 |
| 24-05-23 | 26.29 | +1.12% | 3,599,685 |
| 24-05-22 | 26 | +11.59% | 4,046,038 |
| 24-05-21 | 23.3 | -1.40% | 1,547,251 |
| 24-05-20 | 23.63 | +2.03% | 1,937,154 |
End-of-day quote Shanghai S.E., May 23, 2024
More quotes
Goodwill E-Health Info Co Ltd is a China-based company mainly engaged in medical information business. The Company's main businesses are the development and sales of medical information software, software technical services, the production and sales of purchased software and hardware, and medical equipment. The Company's products include electronic medical record platforms, clinical pathway systems, mobile healthcare systems, digital medical record filing systems and other software-as-a-service (SaaS) products. The Company's products are mainly used in clinical medicine, hospital management, medical research, doctor-patient interaction, medical care integration, medical payment optimization and other fields.
Calendar
2024-08-26
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
25.98
CNY
Average target price
35.5
CNY
Spread / Average Target
+36.64%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -22.26% | 497M | |
| +5.91% | 32.95B | |
| +20.73% | 8.01B | |
| -29.52% | 2.67B | |
| -13.29% | 1.5B | |
| -28.02% | 1.27B | |
| -30.53% | 1.2B | |
| +11.35% | 996M | |
| -38.17% | 864M | |
| -23.12% | 672M |
- Stock Market
- Equities
- 688246 Stock
